BAX and hepatocellular carcinoma: In hepatocellular carcinoma, overexpression of CXCL2 has been implicated in the inhibition of cell proliferation and concurrent promotion of apoptosis through upregulation of pro-apoptotic proteins such as Bax and Caspase-7 [24].